Tubulis (private company)
		See something wrong or missing? Let us know
	
Offices:Munich
			
			Industry:BiotechHealth services
			Business model:B2B
			
			Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology.
					Investors:
					
						
							we tracked 20 investors
						
					
				
				
					You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
					Investments 618.84M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Tubulis
| Name | Criteria | |
|---|---|---|
|  | AbolerIS Pharma 57% | 
 | 
|  | Acesion Pharma 57% | 
 | 
|  | Antag Therapeutics 57% | 
 | 
|  | Arthex Biotech S.L. 57% | 
 | 
|  | Atai Life Sciences 57% | 
 | 
|  | Biofidelity 57% | 
 | 
|  | BoneSupport 57% | 
 | 
|  | CatalYm 57% | 
 | 
|  | Citryll 57% | 
 | 
|  | DeepuII 57% | 
 | 
 Belgium
 Belgium Austria
 Austria Switzerland
 Switzerland Estonia
 Estonia Finland
 Finland Iceland
 Iceland Latvia
 Latvia Lithuania
 Lithuania Norway
 Norway Ireland
 Ireland Italy
 Italy Portugal
 Portugal